,src,lang,text
0,"











Mylan third-quarter profit rises 7per cent on new drug launches

05 Nov 2019, 20:10

Mylan NV reported a 7.4per cent rise in third-quarter profit on Tuesday, as the generic drugmaker benefited from new product launches.
REUTERS: Mylan NV reported a 7.4per cent rise in third-quarter profit on Tuesday, as the generic drugmaker benefited from new product launches.
The company, which in July said it would merge with Pfizer Inc's off-patent branded drugs unit, said net earnings rose to US$189.8 million, or 37 cents per share, in the quarter ended Sept 30 from US$176.7 million, or 34 cents per share, a year earlier.
Advertisement
Advertisement
Total revenue rose to US$2.96 billion from US$2.86 billion.
(Reporting by Saumya Sibi Joseph and Aakash Jagadeesh Babu in Bengaluru; Editing by Anil D'Silva)
Source: Reuters


",en,"











Mylan third-quarter profit rises 7per cent on new drug launches

05 Nov 2019, 20:10

Mylan NV reported a 7.4per cent rise in third-quarter profit on Tuesday, as the generic drugmaker benefited from new product launches.
REUTERS: Mylan NV reported a 7.4per cent rise in third-quarter profit on Tuesday, as the generic drugmaker benefited from new product launches.
The company, which in July said it would merge with Pfizer Inc's off-patent branded drugs unit, said net earnings rose to US$189.8 million, or 37 cents per share, in the quarter ended Sept 30 from US$176.7 million, or 34 cents per share, a year earlier.
Advertisement
Advertisement
Total revenue rose to US$2.96 billion from US$2.86 billion.
(Reporting by Saumya Sibi Joseph and Aakash Jagadeesh Babu in Bengaluru; Editing by Anil D'Silva)
Source: Reuters


"
